Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

HHS Logo Eagle IconU.S. Department of Health and Human Services
napa

Advisory Council on Alzheimer's Research, Care, and Services Meetings

The Advisory Council on Alzheimer's Research, Care, and Services meets quarterly to discuss programs that impact people with Alzheimer's disease and related dementias (AD/ADRD) and their caregivers. Representatives from agencies and organizations that work with dementia treatment and care are invited to present information to the Advisory Council. The public is also given time at each meeting to provide first-hand information of their day-to-day experience.

This section provides the information available for each Advisory Council meeting.

Comments and questions, or alerts to broken links, should be sent to napa@hhs.gov.

2024 Meetings

Past Meetings

April 29-30, 2024 — Advisory Council Meeting

During the meeting on April 29 & 30, 2024, the Advisory Council will hear updates from federal agencies on activities during the last quarter and from panels organized by the clinical care and long-term services and supports (LTSS) subcommittees. On the first day, presenters will discuss care and navigation across health care settings from post-diagnosis through advanced disease. The panels on the second day will focus on challenges with LTSS for people with young-onset dementia and their care partners/families, as well as challenges with dementia among aging populations experiencing homelessness or incarceration.

General Material:

January 22, 2024 — Advisory Council

During the meeting, the Advisory Council heard updates from the field on implementation of disease-modifying therapies for Alzheimer’s disease and outstanding research questions. A panel presented the latest research on diagnosis and development of treatments for other populations and causes of dementia.

General Material:

Presentation Slides:

Videos: